Cita APA

Iguchi, T., Tamada, S., Kato, M., Yasuda, S., Yamasaki, T., & Nakatani, T. (2019). Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: Study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study). BMC Cancer.

Chicago Style Citation

Iguchi, Taro, Satoshi Tamada, Minoru Kato, Sayaka Yasuda, Takeshi Yamasaki, i Tatsuya Nakatani. "Enzalutamide Versus Flutamide for Castration-resistant Prostate Cancer After Combined Androgen Blockade Therapy With Bicalutamide: Study Protocol for a Multicenter Randomized Phase II Trial (the OCUU-CRPC Study)." BMC Cancer 2019.

Cita MLA

Iguchi, Taro, et al. "Enzalutamide Versus Flutamide for Castration-resistant Prostate Cancer After Combined Androgen Blockade Therapy With Bicalutamide: Study Protocol for a Multicenter Randomized Phase II Trial (the OCUU-CRPC Study)." BMC Cancer 2019.